ArticleFrontiers in oncology2022

Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE study.

Akihiko Takeuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.